Clinical trial · Observational
Diagnosing and Treating Low Blood Sugar Levels
Fasting Hypoglycemia: Diagnosis and Treatment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260929-000001
Summary
Brief summary (as posted)
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed....
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hypoglycemia | — | UNRESOLVED | — |
| Insulinoma | Pancreatic Insulinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Patients with hypoglycemia
- description
- Patients with hypoglycemia due to diverse etiologies.
Primary outcomes (1)
- measure
- Treatment Outcomes
- timeFrame
- every 1-3 months
- description
- resolution of hypoglycemia
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Male, females ages \>= 18. 2. Patients with documented fasting blood glucose below 55 mg/dl. 4\. Patients with biochemical evidence for insulinoma or other pancreatic neuroendocrine tumors. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Patients with significant cardiac disease will be excluded. 2. Subjects who are pregnant per self-report. 3. Medically unstable per the assessment of the PI.
References
Publications (3)
- BACKGROUNDBar RS, Gorden P, Roth J, Siebert CW. Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J Clin Endocrinol Metab. 1977 Jun;44(6):1210-3. doi: 10.1210/jcem-44-6-1210. PMID 194912
- BACKGROUNDBlackshear PJ, Rotner HE, Kriauciunas KA, Kahn CR. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med. 1983 Aug;99(2):182-4. doi: 10.7326/0003-4819-99-2-182. PMID 6349454
- BACKGROUNDComi RJ, Gorden P. Approach to hypoglycemia in adults. Compr Ther. 1987 Mar;13(3):38-44. No abstract available. PMID 3568598